Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | YAF2 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | MYO15B | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | CBX1 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | MYO1F | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | GPR173 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-07 |
mRNA | MGST2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | KHDC1 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | NFYB | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |